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EditorialReflecting on the Past and Looking Forward to the
Future of Bridging Chemistry and BiologyIt might seem to some that it was only yesterday when Stuart
Schreiber and K. C. Nicolaou came together to launch a new
journal called Chemistry & Biology. At that time, 20 years
ago, they recognized that a growing number of researchers
were operating at the interface of chemistry and biology but
had limited options when it came to publishing their work.
Thus, supported by their peers and emboldened by the quality
and significance of insights that came out of these research ef-
forts, Schreiber and Nicolau initiated Chemistry & Biology, a
new journal for a new field, to promote interdisciplinary
research and encourage crosstalk between chemists and biol-
ogists (Figure 1). The basic intention of the new journal was to
make science accessible to both sets of readers. Chemistry &
Biology would then offer a unique place where ideas from
both areas would cross-pollinate and, to take the metaphor a
step further, blossom into a research discipline with the ability
to tackle both chemical and biological questions with the same
energy, intensity, and drive and to offer solutions to problems
spanning cell biology, biochemistry, biotechnology, pharma-
cology, drug discovery and development, and organic chemis-
try. The interdisciplinary efforts did indeed flourish, and with
them the new journal, which was over the years supported by
the launch editors, a dedicated group that over the years
included Patrick Baeuerle, Gerald Joyce, Gregory Verdine, Pe-
ter Leadlay, Thomas Kodadek, Ronald Breaker, Michael Famu-
lok, Peter Seeberger, and Wolfgang Wohlleben, and in-house
editors Rebecca Ward, Victoria Mountain, Gail Mitchell Emils-
son, and Lara Szewczak. The journal continues to be enthusi-
astically guided by the current editorial team, who are behind
this editorial and this special issue, and supported by past
and present members of the editorial board and the members
of a broad scientific community, who contribute to the journal
as authors and reviewers.
The focus of the journal on publishing reports that combine
chemistry and biology in creative ways has remained constant
over the years. We are broadly interested in publishing research
results across a number of different topics, including reports that
provide insights into how small molecule-mediated cellular pro-
cesses can be studied, modulated, reconstructed, and de-
signed; the mechanisms of formation and transformation of
small molecules; peptide and protein engineering and design;
metabolic engineering; synthetic biology; systems-level ana-
lyses that include metabolomics, lypidomics, glycomics, and
proteomics; how small molecules are employed for signaling
and communication purposes at different levels (intra- and inter-
cellular and intra- and interspecies); how viruses, cells, and or-
ganisms develop resistance to small molecules; how small mole-
cule protein conjugates are generated, distributed, and function;
natural products, their biosynthesis and mechanism of action;
structure, function, mechanism, and engineering of enzymes;
chemistry, biology, and technology of RNAs andDNAs; chemical
biology of lipids and sugars; and numerous studies that employ
small molecule-based probes to illuminate biology, enableChemistry & Biology 2biotechnology, or inform medicine. As you may appreciate, this
list can go on and on and continues to be in flux, as the field
evolves and transforms itself and uncovers new spheres of inter-
est and new fields in which a combination of chemical thinking
and biological inquiry can have a meaningful impact on finding
the answers to challenging questions.
We think that the reviews and perspectives included in this
special anniversary issue highlight the breadth of our interests.
A perspective by one of our founding editors, K.C. Nicolaou, ar-
gues for the need to initiate transdisciplinary collaborations be-
tween chemistry, biology, and medicine in order to push the
boundaries of current drug discovery and development pro-
cesses. Another issue of relevance to these processes is the
widespread use of Lipinski’s rule of five, and in their review,
Doak et al. elaborate on the importance of going beyond this
rule and accessing the chemical space of compounds that do
not conform to it. A long-standing challenge for drug discovery
and development has been the ability to target protein-protein
interactions, and Arkin et al. discuss how these efforts have
evolved over time and yielded some interesting examples that
are currently in clinical trials. Murry and Baeuerle provide a
perspective on developing biologicals as human therapies,
thus highlighting one of the fastest growing areas of interest to
pharmaceutical and biotechnology industries. Metabolism is
the topic of two reviews that discuss it from different angles:
DeLaBarre et al. review current efforts to target metabolism as
a way of treating cancer, and Medina-Cleghorn and Nomura re-
view innovative metabolic mapping techniques. Screening tech-
nologies for small molecule discovery are the topic of the review
by Janzen, who also provides a historical view on how screening
emerged as a specific scientific discipline. Functional RNAs and
DNAs remain one of the core interests of the journal and two per-
spectives, by Mayer and Famulok and by Joyce and Breaker,
discuss how far we have come in this area since the launch of
the journal. One of the big outstanding issues in natural product
discovery is how to successfully mine the microbiome, and the
review by Milshteyn et al. offers a summary of the currently em-
ployed strategies. Using small molecules as probes to uncover
new insights into biology and physiology has been a core inter-
est of the journal from its inception, and a perspective by Koda-
dek offers arguments for using ‘‘antigen surrogates’’ as probes
to study immunology. Focusing on small molecule probes are
reviews by van Hattum and Waldmann, which summarizes the
most recent work on developing chemical biology tools to con-
trol RAS signaling; by Finley and Copeland on small molecule
modulators of chromatin remodelers; and by Huber and Sakmar
on probes for GPCRs. Finally, Finn and McKay and Rakhit et al.
offer two different views on using chemical biology strategies to
modulate protein function via Click chemistry or via manipu-
lating protein levels on a posttranslational basis, respectively.
Chemistry & Biology continues to evolve with the field and
has been making changes to offer the authors and reviewers
an exceptional level of open interaction with the Editors. For1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1035
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Editorialexample, we offer direct access to the in-house editor, Milka
Kostic, via Skype or phone to all the authors who are invited
to prepare a revision for the further consideration by the journal,
and we are pleased with how many of our authors have taken
advantage of this opportunity to discuss their work directly. The
Editors are also available to provide advice on whether a given
study is a strong candidate for submission through presubmis-
sion inquiry. The bottom line is that we recognize that every pa-
per we consider is the result of a great deal of effort on the part1036 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltof the authors, and we are committed to making the process of
editorial and peer review evaluation as open, fair, constructive,
and timely as possible. Recognizing the importance of making
the accepted manuscript available soon after acceptance, we
now publish all articles online ahead of print, and with this issue
we will start broadcasting news about the newly published con-
tent through a dedicated Twitter channel, @CellChemBiol, and
we hope the community joins the 140 character conversations.
Finally, as the field of chemical biology expands, we look for-
ward to growing with it, and to that end we have recently intro-
duced the Resource, a new article type to facilitate publication
of chemical tools and methods that enrich currently available
toolkit for basic and translational biomedical research. We
also introduced Chemistry & Biology Select, a new journal sec-
tion in which we provide brief comments on a few editorially
selected articles from recent literature that might be of high
general interest to chemical biology community. We encourage
you to explore our new features.
Chemistry & Biology is now 20 years young, and going forward
we hope to remain relevant in chemical biology community as
one of the premier journals that support cross-pollination of
chemistry and biology and dissemination of the fascinating dis-
coveries that are inspired by the chemical biology way of doing
research.
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